127 related articles for article (PubMed ID: 11200929)
41. Insulin-like growth factor-1 and insulin-like growth factor-binding protein-1 in patients with polycystic ovary syndrome during clomiphene citrate therapy.
Ozerkan K; Uncu G; Tüfekçi M
Int J Gynaecol Obstet; 2010 Jan; 108(1):71-2. PubMed ID: 19782978
[No Abstract] [Full Text] [Related]
42. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas.
Hill DJ; Hogg J; Petrik J; Arany E; Han VK
J Endocrinol; 1999 Feb; 160(2):305-17. PubMed ID: 9924201
[TBL] [Abstract][Full Text] [Related]
43. Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation.
Price WA; Stiles AD; Moats-Staats BM; D'Ercole AJ
Endocrinology; 1992 Mar; 130(3):1424-32. PubMed ID: 1371449
[TBL] [Abstract][Full Text] [Related]
44. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.
el-Roeiy A; Chen X; Roberts VJ; Shimasakai S; Ling N; LeRoith D; Roberts CT; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth.
Giudice LC; de Zegher F; Gargosky SE; Dsupin BA; de las Fuentes L; Crystal RA; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1995 May; 80(5):1548-55. PubMed ID: 7538146
[TBL] [Abstract][Full Text] [Related]
46. [The relationships of the serum concentrations of insulin-like growth factors in fetal rats with intrauterine growth retardation].
Bai B; Yao Y; Li W; Zeng Y; Yang F
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):307-8, 312. PubMed ID: 12600117
[TBL] [Abstract][Full Text] [Related]
47. Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.
Begum MR; Akhter S; Ehsan M; Begum MS; Khan F
J Obstet Gynaecol Res; 2013 May; 39(5):966-73. PubMed ID: 23379651
[TBL] [Abstract][Full Text] [Related]
48. Developmental changes in hepatic IGF-2 and IGFBP-2 mRNA levels in intrauterine growth-retarded and control swine.
Kampman KA; Ramsay TG; White ME
Comp Biochem Physiol B; 1993 Feb; 104(2):415-21. PubMed ID: 7681741
[TBL] [Abstract][Full Text] [Related]
49. Fetal growth in relation to maternal and fetal IGF-axes: a systematic review and meta-analysis.
Elhddad AS; Lashen H
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):997-1006. PubMed ID: 23745729
[TBL] [Abstract][Full Text] [Related]
50. Intrafollicular content of growth factors and steroids in PCO and their response to ovulation induction treatment.
Genazzani AR; Battaglia C; D'Ambrogio G; Umoh GG; Droghini F; Artini PG
Eur J Obstet Gynecol Reprod Biol; 1994 May; 55(1):33-4. PubMed ID: 7958137
[No Abstract] [Full Text] [Related]
51. [The role of inhibins in functions and dysfunctions of female reproduction--Part II].
Meczekalski B; Podfigurna-Stopa A
Pol Merkur Lekarski; 2009 Jun; 26(156):676-8. PubMed ID: 19711741
[TBL] [Abstract][Full Text] [Related]
52. Oxidation of placental insulin and insulin-like growth factor receptors in mothers with diabetes mellitus or preeclampsia complicated with intrauterine growth restriction.
Robajac D; Masnikosa R; Miković Ž; Mandić V; Nedić O
Free Radic Res; 2015; 49(8):984-9. PubMed ID: 25812587
[TBL] [Abstract][Full Text] [Related]
53. The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration.
Panidis D; Tziomalos K; Papadakis E; Kandaraki EA; Katsikis I
Hormones (Athens); 2013; 12(2):192-200. PubMed ID: 23933688
[TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries.
Holly JM; Eden JA; Alaghband-Zadeh J; Carter GD; Jemmott RC; Cianfarani S; Chard T; Wass JA
Clin Endocrinol (Oxf); 1990 Jul; 33(1):53-64. PubMed ID: 1698131
[TBL] [Abstract][Full Text] [Related]
55. Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome.
Morris RS; Karande VC; Dudkiewicz A; Morris JL; Gleicher N
Fertil Steril; 1999 Mar; 71(3):452-6. PubMed ID: 10065781
[TBL] [Abstract][Full Text] [Related]
56. Effect of a high maternal dietary intake during mid-gestation on components of the utero-placental insulin-like growth factor (IGF) system in adolescent sheep with retarded placental development.
Gadd TS; Aitken RP; Wallace JM; Wathes DC
J Reprod Fertil; 2000 Mar; 118(2):407-16. PubMed ID: 10864806
[TBL] [Abstract][Full Text] [Related]
57. Obesity and its relationship to infertility in men and women.
Loret de Mola JR
Obstet Gynecol Clin North Am; 2009 Jun; 36(2):333-46, ix. PubMed ID: 19501317
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor binding proteins and breast cancer.
Subramanian A; Sharma A; Mokbel K
Breast Cancer Res Treat; 2008 Jan; 107(2):181-94. PubMed ID: 17611793
[No Abstract] [Full Text] [Related]
59. Polycystic ovary syndrome: Endometrial markers.
Piltonen TT
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():66-79. PubMed ID: 27156350
[TBL] [Abstract][Full Text] [Related]
60. [Lipid peroxidation in the uterus-placenta-fetus system in cases of nephropathy and fetal hypotrophy].
Sieroń G; Drózdz M; Jendryczko A; Tomala J
Ginekol Pol; 1988 Oct; 59(10):618-23. PubMed ID: 3248753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
